Page 973 - Cardiac Nursing

LWBK340-ind_p941-958.qxd 7/1/09 10:37 AM Page 949 Aptara
LWB K34 0-i nd_ p94 1-9 58. qxd 7 / 1 / 09 10 :37 AM P a g e 94 9 A pta ra

Index 949

IN SUDDEN DEATH n DIETARY MANAGEMENT CARDIAC EFFECTS OF n
TIME DOMAIN ANALYSIS T DIETARY CHANGE STRATEGY CAUSES OF T
T
T
(EMATOCRIT (CT DIETARY RECOMMENDATION n AND TOTAL BODY MAGNESIUM DEPLETION
(EMATOLOGIC STUDIES LIPID EFFECTS DIET PATTERNS n VASCULAR EFFECTS OF
OF #"# COUNT n PHARMACOLOGIC MANAGEMENT OF (YPONATREMIA T
LABORATORY MEASUREMENT OF CLASSES OF HYPOLIPIDEMIC DRUGS n (YPOPOLARIZING EFFECT
(EMATOPOIESIS GENERAL ADHERENCE STRATEGY
(EMATOPOIETIC CELLS LIPID CRITERIA AND GOALS I
COAGULATION FACTORS (YPERMAGNESEMIA
HIERARCHY F CARDIAC EFFECTS OF )!"0 THERAPY n D

PLATELETS n CAUSES OF T )-! BYPASS GRAFTS
RED BLOOD CELLS FOR n VASCULAR EFFECTS OF )MAGING 7INDOWS n

WHITE BLOOD CELLS n T (YPERNATREMIA n T )MPAIRED SLEEP F
(EMIBLOCK 3EE &ASCICULAR BLOCK (YPERPOLARIZED )MPEDANCE CARDIOGRAPHY )#' n
(EMODYNAMIC INDICATOR THRESHOLDS T (YPERTENSION (4. )MPEDANCE MONITORING INTRATHORACIC
(EMODYNAMIC INDICES T IN ADULTS )MPLANTABLE CARDIOVERTER DEFIBRILLATOR )#$

F

F
F
F
D
D
D
D
D
D
D
D

T
T
(EMODYNAMIC INDICES FUNCTIONAL T F AWARENESS T Fn F D D D D
RESPIRATORY VARIATION CAUSES OF n D
IN #60 IN CHILDREN ANXIETY AND 1/, IN n
IN 3"0 n CLINICAL MANIFESTATIONS OF DETECTION ENHANCEMENT n
INDICES INTO PLAN OF CARE n ASSESSMENT OF n DEVELOPMENT OF n
LIMITATIONS OF n DIAGNOSIS OF n EXTERNAL PRECAUTIONS
MECHANICAL VENTILATION EVALUATION OF FOLLOW UP CARE IN n D

PULSE PRESSURE VARIATION PROGNOSIS FUNCTIONAL CHARACTERISTICS n F
SPONTANEOUS VENTILATION n SIGNS AND SYMPTOMS OF n HIGH RISK PATIENT n
(EMOGLOBIN VASCULAR CHANGES OF n INDICATION OF USE n
(EMOLYTIC ANEMIA DEFINITION OF MAGNET MODE
(EMORRHAGE 3EE "LEEDING DURATION OF MAKING OF D
(EMOSTASIS EDUCATION FOR MODES OF OPERATION
COAGULATION CASCADE n EPIDEMIOLOGY OF n BRADYCARDIA PACING
ENDOTHELIUM ROLL IN FAMILY HISTORY IN MAGNET MODE D
FIBRINOLYSIS GENDER DIFFERENCE IN n VENTRICULAR FIBRILLATION THERAP n
NATURAL ANTICOAGULANT SYSTEMS IN n GENETIC FACTORS IN VENTRICULAR TACHYCARDIA THERAPY n
PLATELET PHASE n GEOGRAPHIC DIFFERENCE IN PACEMAKER INTERACTION n
VASCULAR SPASM HEMODYNAMIC PROFILES WITH PULMONARY TYPE POTENTIAL COMPLICATIONS OF D
D
D
(EPARIN INDUCED THROMBOCYTOPENIA T PRACTICE GUIDELINES OF Dn D
CLINICAL PRESENTATION HEMODYNAMICS OF n PRE POST OPERATIVE NURSING CARE n
ETIOLOGY OF n INCOME IN REGISTRY D
MEDICAL MANAGEMENT n LIFE STYLE MODIFICATIONS IN T SEX AND RACIAL DIFFERENCE IN
NURSING INTERVENTIONS n PARENTERAL DRUGS FOR T SYNCOPE OF UNKNOWN ORIGIN
T
T
PATHOPHYSIOLOGY PREVENTION n )MMUNOSUPPRESSIVE DRUG SIDE EFFECTS T
(ERBAL PRODUCTS PRIMARY T
(ERBAL REMEDIES n PROGNOSIS )MPLANTABLE HEMODYNAMIC MONITORS )(-S

(EXAXIAL REFERENCE SYSTEM F SECONDARY n D )MPULSE
(IGH DENSITY LIPID ($, T STRATEGIES TO PROMOTE CONTROL OF T ABNORMAL CONDUCTION
(IGH GRADE !6 BLOCK 3EE ALSO !DVANCED !6 TREATMENT ALGORITHM IN ADULTS F CONDUCTION BLOCK

BLOCK TREATMENT OF F PHASE BLOCK F

(IGH SENSITIVITY # REACTIVE PROTEIN HS #20 ACHIEVING "0 CONTROL n REENTRY n
F

F T BASED ON *.# GUIDELINES n ABNORMAL INITIATION n
F
(IGH SENSITIVITY #20 HS#20 n BEYOND *.# GUIDELINES n GENERATION 3EE !UTOMATICITY
(IS 0URKINJE SYSTEM COMBINATION DRUGS FOR T 0OINT OF MAXIMAL
(-' #O! REDUCTASE INHIBITORS STATINS COMMUNITY ROLE )NCRETIN MIMETICS
T HEALTH CARE ORGANIZATION ROLE )NDETERMINATE AXIS
(OLISTIC HEALTH CARE HEALTH CARE PROVIDER ROLE n )NDICATOR DILUTION METHODS
(OLOSYSTOLIC MURMURS NONPHARMACOLOGIC MANAGEMENT OF n )NFARCTION
(OMANS SIGN PATIENT ROLES INDICATIVE CHANGES OF
(OMEOPATHIC MEDICINE PHARMACOLOGIC MANAGEMENT OF n RIGHT VS LEFT T
(OMOCYSTEINE (CY T (YPERTENSIVE RETINOPATHY T 26 n
T
T
(UMAN GENOME PROJECT ('0 (YPERTRIGLYCERIDEMIA n PATIENT WITH NCPn NCP
(YPERACUTE REJECTION n (YPERTROPHIC CARDIOMYOPATHY (#- )NFECTIVE ENDOCARDITIS n 3EE %NDOCARDITIS
(YPERCALCEMIA INFECTIOUS

CARDIAC EFFECTS OF (YPOALPHALIPOPROTEINEMIA )NFERIOR 6ENA #AVA )6# F
CAUSES OF T (YPOCALCEMIA )NFLAMMATION F
DEFINITION OF CARDIAC EFFECTS OF BRAIN NATRIURETIC PEPTIDE
VASCULAR EFFECTS OF n CAUSES OF T CIRCULATING ADHESION MOLECULES n
(YPERCHOLESTEROLEMIA n DEFINED DEFINITION OF
F
F
COMBINED DYSLIPIDEMIAS VASCULAR EFFECTS OF FIBRINOGEN
FAMILIAL SEVERE (YPOKALEMIA HIGH SENSITIVITY C REACTIVE PROTEIN n
HYPERTRIGLYCERIDEMIA n CARDIAC EFFECTS OF n )NFUNDIBULUM
(YPERKALEMIA CAUSE OF n T )NOSITOL TRIPHOSPHATE
CARDIAC EFFECTS OF n VASCULAR EFFECTS OF )NOTROPIC AGENTS
CAUSES OF T (YPOLIPIDEMIC DRUGS )NSOMNIA
D
D
VASCULAR EFFECTS OF CLASSES OF D n DEFINITION OF
(YPERLIPIDEMIA (YPOMAGNESEMIA MEDICATIONS USED D
TYPES OF D